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background: Emerging evidence suggest that home BP measurements provide additional information regarding BP control. Most studies reported 
office and some ambulatory BP changes in renal denervation studies.. Home BP data are scarce.
methods and results: The EnligHTN-I first-in-human study was designed to assess the safety and efficacy of a multi-electrode ablation system in 
patients with drug-resistant hypertension. The primary end point was change in office BP, but 24 hr ambulatory and home BPs were also collected. A 
total of 46 pts (av. age 60±10yrs, on 4.7±1.0 meds) were enrolled. Of these pts 33% were female, 98% were white, 20% had Coronary Artery Disease, 
59% had hyperlipidemia, 33% had type II Diabetes Mellitus, and 30% had history of sleep apnea. Home BP measurements were in the morning 
and evening assessed (in triplicates) for at least 14 days prior to procedure and each follow-up visit. BPs were averaged as morning and afternoon 
pressures and summarized at weekly intervals. Thus average weekly BP for each patient is derived from up to 42 BP measurements. Baseline average 
office BP was 176/96 mmHg and average 24 hr ambulatory BP 150/83 mmHg. Average reductions (mmHg) of office BP at 1, 3, 6 and 12 months 
were -28/10, -27/10, -26/10 and -27/11 mmHg (p<0.001) respectively and for 24hr ambulatory BP -10/5, -10/5, -10/6 and -7/4 for 12 month 
(p<0.001). Average home BPs were as follows. Baseline at weeks -3,-2,-1 prior to the procedure: 157/89 ,159/91 , 157/90 , at month 1(weeks 
-2,-1) were 149/87 , 150/ 86, at 3 months (wks -2,-1) 149/85, 150/83 , at 6 months 148/83 , 148/83 and at 12 months 151/85 , and 150/84 
mmHG (P<0.001 for all). The morning home BP measures were consistently 3 mmHg higher than the afternoon BP measures and the average 
paralleled the daytime ambulatory BP measurement and after the 1 month follow-up it was similar to office BP measures.
conclusions: Data up to 12 months indicate that renal denervation using the EnligHTN multi-electrode catheter is effective in lowering home BP. 
Although the reduction in home BP is less in magnitude it is still clinically meaningful at all time points.. Home BP measurements parallel the 24 hr 
measurements and they can be a standard measurement in renal denervation studies.
